Table 1.
Average Baseline | Change Between Baseline and Death, % |
||||
---|---|---|---|---|---|
Value | Control | 1x-HLU | 2x-HLU | 3x-HLU | |
Metaphysis | |||||
Body Mass, g | 28 ± 0.53 | 15 ± 4.5* | 14 ± 5.1* | 9.8 ± 5.5* | 11 ± 4.8* |
BV/TV, % | 8.6 ± 0.35 | −36 ± 6.4* | −41 ± 15* | −47 ± 9.4*,a | −46 ± 9.0*,a |
Tb.N, 1/mm | 4.9 ± 0.08 | −20 ± 5.3* | −20 ± 5.3* | −24 ± 4.0* | −20 ± 4.6* |
Tb.Th, μm | 41 ± 0.73 | 10 ± 6.1* | 8.8 ± 5.1* | 4.1 ± 3.6*a | 3.8 ± 4.6*a |
Tb.Sp, mm | 0.20 ± 0.003 | 26 ± 8.8* | 24 ± 9.0* | 31 ± 6.5* | 25 ± 7.5* |
Conn.D, 1/mm3 | 35 ± 4.2 | 77 ± 17* | 77 ± 21* | 76 ± 18* | 78 ± 17* |
Diaphysis | |||||
Ct.Ar, mm2 | 0.82 ± 0.01 | 2.1 ± 5.1 | 4.0 ± 5.5* | 0.49 ± 5.4 | −2.8 ± 5.1a,b |
Ct.Th, μm | 180 ± 2.8 | −3.4 ± 6.3 | 0.95 ± 4.8 | −3.2 ± 6.4 | −4.3 ± 6.3 |
Ma.Ar, mm2 | 1.1 ± 0.02 | 4.5 ± 5.0* | 3.1 ± 3.9* | 3.7 ± 4.3* | 1.6 ± 3.5 |
Tt.Ar, mm2 | 1.9 ± 0.03 | 3.3 ± 3.1* | 3.7 ± 3.6* | 2.1 ± 2.4* | −0.23 ± 1.6a,b |
Ct.Ip, mm4 | 0.42 ± 0.01 | 5.0 ± 8.1* | 7.1 ± 8.8* | −3.0 ± 6.0b | −1.1 ± 5.5b |
Ct.TMD, mgHa/ccm | 1100 ± 12 | 1.2 ± 1.9* | 4.2 ± 1.8* | 0.18 ± 2.6b | 1.0 ± 2.7b |
ICP, % | 98 ± 0.74 | 0.44 ± 1.1 | −0.21 ± 0.98 | −0.11 ± 0.55 | −0.04 ± 0.63 |
BSI, mm4 mgHA/ccm | 160 ± 21 | 13 ± 12* | 17 ± 7* | 2.8 ± 6.7a,b | 1.1 ± 13a,b |
Data are shown as means ± SD. Letters denote significant differences (P < 0.05) between groups.
Significantly different from baseline, P < 0.05. aAny group significantly different from control. b2x- or 3x-HLU significantly different from 1x-HLU. c3x-HLU different from 2x-HLU. BV/TV, trabecular bone volume fraction; Tb.Th, trabecular thickness; Tb.N, trabecular number; Tb.Sp, trabecular separation; Conn.D, connectivity density; Ct.Ar, cortical bone area; Ct.Th, cortical bone thickness; Ma.Ar, marrow area; Tt.Ar, total area; Ct.TMD, cortical tissue mineral density; Ct.Ip, cortical polar moment of inertia; ICP, intracortical porosity; BSI, cortical bending strength index.